Birch pollen, air pollution and their interactive effects on airway symptoms and peak expiratory flow in allergic asthma during pollen season - a panel study in Northern and Southern Sweden.


Journal

Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645

Informations de publication

Date de publication:
06 07 2022
Historique:
received: 26 01 2022
accepted: 09 06 2022
entrez: 6 7 2022
pubmed: 7 7 2022
medline: 9 7 2022
Statut: epublish

Résumé

Evidence of the role of interactions between air pollution and pollen exposure in subjects with allergic asthma is limited and need further exploration to promote adequate preventive measures. The objective of this study was to assess effects of exposure to ambient air pollution and birch pollen on exacerbation of respiratory symptoms in subjects with asthma and allergy to birch. Thirty-seven subjects from two Swedish cities (Gothenburg and Umeå) with large variation in exposure to both birch-pollen and air pollutants, participated in the study. All subjects had confirmed allergy to birch and self-reported physician-diagnosed asthma. The subjects recorded respiratory symptoms such as rhinitis or eye irritation, dry cough, dyspnoea, the use of any asthma or allergy medication and peak respiratory flow (PEF), daily for five consecutive weeks during two separate pollen seasons and a control season without pollen. Nitrogen oxides (NO During pollen seasons all symptoms and medication use were higher, and PEF was reduced in the subjects. In regression analysis, exposure to pollen at lags 0 to 2 days, and lags 0 to 6 days was associated with increased ORs of symptoms and decreased RRs for PEF. Pollen and air pollution interacted in some cases; during low pollen exposure, there were no associations between air pollution and symptoms, but during high pollen exposure, O Pollen and air pollutants interacted to increase the effect of air pollution on respiratory symptoms in allergic asthma. Implementing the results from this study, advisories for individuals with allergic asthma could be improved, minimizing the morbidities associated with the condition.

Sections du résumé

BACKGROUND
Evidence of the role of interactions between air pollution and pollen exposure in subjects with allergic asthma is limited and need further exploration to promote adequate preventive measures. The objective of this study was to assess effects of exposure to ambient air pollution and birch pollen on exacerbation of respiratory symptoms in subjects with asthma and allergy to birch.
METHODS
Thirty-seven subjects from two Swedish cities (Gothenburg and Umeå) with large variation in exposure to both birch-pollen and air pollutants, participated in the study. All subjects had confirmed allergy to birch and self-reported physician-diagnosed asthma. The subjects recorded respiratory symptoms such as rhinitis or eye irritation, dry cough, dyspnoea, the use of any asthma or allergy medication and peak respiratory flow (PEF), daily for five consecutive weeks during two separate pollen seasons and a control season without pollen. Nitrogen oxides (NO
RESULTS
During pollen seasons all symptoms and medication use were higher, and PEF was reduced in the subjects. In regression analysis, exposure to pollen at lags 0 to 2 days, and lags 0 to 6 days was associated with increased ORs of symptoms and decreased RRs for PEF. Pollen and air pollution interacted in some cases; during low pollen exposure, there were no associations between air pollution and symptoms, but during high pollen exposure, O
CONCLUSIONS
Pollen and air pollutants interacted to increase the effect of air pollution on respiratory symptoms in allergic asthma. Implementing the results from this study, advisories for individuals with allergic asthma could be improved, minimizing the morbidities associated with the condition.

Identifiants

pubmed: 35794604
doi: 10.1186/s12940-022-00871-x
pii: 10.1186/s12940-022-00871-x
pmc: PMC9258213
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

63

Informations de copyright

© 2022. The Author(s).

Références

Environ Pollut. 2018 Mar;234:707-715
pubmed: 29241157
Environ Health. 2020 Dec 7;19(1):130
pubmed: 33287833
Clin Exp Allergy. 2017 Nov;47(11):1426-1435
pubmed: 28608416
Clin Exp Allergy. 2018 Jul;48(7):798-805
pubmed: 29526044
Allergy. 2017 May;72(5):713-722
pubmed: 27874202
J Investig Allergol Clin Immunol. 2018;28(2):91-97
pubmed: 29345235
J Epidemiol Community Health. 2012 Sep;66(9):796-802
pubmed: 21690606
Environ Pollut. 2020 Aug;263(Pt A):114526
pubmed: 32283467
Allergy. 2019 Sep;74(9):1703-1715
pubmed: 31021427
J Allergy Clin Immunol. 2006 Sep;118(3):551-9; quiz 560-1
pubmed: 16950269
BMJ Open. 2020 Jan 10;10(1):e029069
pubmed: 31924628
Ann Allergy Asthma Immunol. 2001 Oct;87(4):311-8
pubmed: 11686424
Evid Based Ment Health. 2019 Nov;22(4):153-160
pubmed: 31563865
World Allergy Organ J. 2019 May 09;12(5):100036
pubmed: 31191792
Allergy. 2020 Mar;75(3):576-587
pubmed: 31512243
Environ Sci Technol. 2017 Apr 18;51(8):4119-4141
pubmed: 28326768
PLoS One. 2013 Nov 20;8(11):e80147
pubmed: 24278250
Eur Respir J. 1999 Oct;14(4):902-7
pubmed: 10573240
Eur Respir J. 1993 Sep;6(8):1109-15
pubmed: 8224125
J Allergy Clin Immunol Pract. 2020 Mar;8(3):1063-1073.e4
pubmed: 31786252
Lancet. 2018 Feb 3;391(10119):462-512
pubmed: 29056410
J Allergy Clin Immunol. 2020 Mar;145(3):834-842.e6
pubmed: 31983528
Glob Chang Biol. 2021 Nov;27(22):5934-5949
pubmed: 34363285
Environ Res. 2020 Mar;182:109118
pubmed: 32069747
Allergy. 2019 Jul;74(7):1237-1248
pubmed: 30829410
Sci Total Environ. 2021 Feb 25;757:143924
pubmed: 33310575
Environ Monit Assess. 2021 Sep 27;193(10):674
pubmed: 34570284
Respir Med. 2015 Sep;109(9):1089-104
pubmed: 26073963
Stat Med. 2010 Sep 20;29(21):2224-34
pubmed: 20812303
Eur Respir J. 2002 Sep;20(3):763-76
pubmed: 12358357
Environ Pollut. 2018 Nov;242(Pt A):880-886
pubmed: 30041161
Int Arch Allergy Immunol. 2012;158(4):397-404
pubmed: 22487690
Environ Res. 2021 Jan;192:110296
pubmed: 33031812
Eur Respir J. 2000 Apr;15(4):716-24
pubmed: 10780764
Lancet. 2014 May 3;383(9928):1581-92
pubmed: 24792855
Thorax. 2016 Jan;71(1):35-44
pubmed: 26574583
BMC Public Health. 2012 Mar 19;12:204
pubmed: 22429515
Eur Respir J. 1998 Oct;12(4):900-5
pubmed: 9817166

Auteurs

Hanne Krage Carlsen (HK)

Section of Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 16A, 40530, Gothenburg, Sweden. hanne.krage.carlsen@amm.gu.se.

Susanna Lohman Haga (SL)

Section of Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 16A, 40530, Gothenburg, Sweden.

David Olsson (D)

Department of Public Health and Clinical Medicine, University Hospital, Sustainable Health, Umeå University, Building 1A, 4st, 901 87, Umeå, Sweden.

Annelie F Behndig (AF)

Section of Medicine, Department of Public Health and Clinical Medicine, University Hospital, Umeå University, Building 1A, 4st, 901 87, Umeå, Sweden.

Lars Modig (L)

Department of Public Health and Clinical Medicine, University Hospital, Sustainable Health, Umeå University, Building 1A, 4st, 901 87, Umeå, Sweden.

Kadri Meister (K)

Department of Statistics, USBE, Social Sciences Building Level 2 (ground floor), Umeå University, 90187, Umeå, Sweden.

Bertil Forsberg (B)

Department of Public Health and Clinical Medicine, University Hospital, Sustainable Health, Umeå University, Building 1A, 4st, 901 87, Umeå, Sweden.

Anna-Carin Olin (AC)

Section of Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 16A, 40530, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH